Overcoming the transmembrane protein degradation challenge: A novel ERAD-based approach
-
-
REFERENCES
[1] Tsai J.M., Nowak R.P., Ebert B.L., et al. (2024). Targeted protein degradation: From mechanisms to clinic. Nat. Rev. Mol. Cell Biol. 25:740−757. DOI:10.1038/s41580-024-00729-9 [2] Riching K.M., Caine E.A., Urh M., et al. (2022). The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation. Chem. Soc. Rev. 51:6210−6221. DOI:10.1039/d2cs00339b [3] Zhu R., Zhang H., and Chen P.R. (2025). Targeted protein degradation in the transmembrane and extracellular space. Science 390:eadx5094. DOI:10.1126/science.adx5094 [4] Song H., Wang W., Mei T., et al. (2026). Hijacking ERAD for targeted degradation of transmembrane proteins. Cell 189: 1768-1784 e1724. DOI: 10.1016/j.cell.2026.01.018 [5] Christianson J.C., Jarosch E., and Sommer T. (2023). Mechanisms of substrate processing during ER-associated protein degradation. Nat. Rev. Mol. Cell Biol. 24:777−796. DOI:10.1038/s41580-023-00633-8 -
ABOUT THIS ARTICLE
Cite this article:
Qin G. (2026). Overcoming the transmembrane protein degradation challenge: A novel ERAD-based approach. The Innovation Life 4:100215. https://doi.org/10.59717/j.xinn-life.2026.100215
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Qin G. (2026). Overcoming the transmembrane protein degradation challenge: A novel ERAD-based approach. The Innovation Life 4:100215. https://doi.org/10.59717/j.xinn-life.2026.100215
Format
Content
DownLoad:
-
Figure 1.
Mode of action of ERADEC and conventional meTPD platforms
